Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting.

Treatment with intravitreal injections of anti-vascular endothelial growth factors, like aflibercept, has revolutionized the management of diabetic macular edema. The purpose of this study is to evaluate the 2-year results of treatment with aflibercept in newly diagnosed, treatment-naive patients with diabetic macular edema in a real-life setting in a tertiary hospital of Southwestern Greece.In this retrospective, real-life, single-center,...